Treatment of Dupuytren's disease with collagenase

Details Treatment of Dupuytren's disease with collagenase Treatment of Dupuytren's disease with collagenase

1994-08-22

1996-12-31

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

A61K 3848

Patent

active

055891713

ABSTRACT:
Dupuytren's disease is treated by applying collagenase to the affected palmar fascia.

REFERENCES:
patent: 3678158 (1972-07-01), Sussman
patent: 4174389 (1979-11-01), Cope
patent: 4338300 (1982-07-01), Gelbard
patent: 4485088 (1984-11-01), Chvapil
patent: 4524065 (1985-06-01), Pinnell
patent: 4645668 (1987-02-01), Pinnell
patent: 5173295 (1992-12-01), Wehling
patent: 5279825 (1994-01-01), Wehling
Bailey et al., Clinical Science & Molecular Medicine 53: 499-502 (1977).
McCarthy, Journal of Hand Surgery 17B:356 (Br 1992).
Murrell G A, An insight into Dupuytren's contracture, 1992; 74, 156-60.
Bromley, L, The collagen changes of Dupuytren's contracture, 1991; 16, 263-6.
Murrell, G A, Scientific comment, Basic science of Dupuytren's disease, Ann. Chir. Main. Memb. Super. 1993; 11, 355-61.
Ryvedik B, Microvascular response to locally injected collagenase, Scand. J. Plast. Reconstr. Surg. 1989; 23, 17-21.
Ryvedik B, Effects of collagenase on nerve tissue, 1985; 10, 562-6.

Affiliated with

Also associated with

Rating

Treatment of Dupuytren's disease with collagenase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of Dupuytren's disease with collagenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Dupuytren's disease with collagenase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1140112